Krka of Slovenia Says Net Income Drops 3% to 90.1 Million Euros

Krka Group d.d., Slovenia’s biggest drugmaker, said first-half net income fell 3 percent to 90.1 million euros ($110 million).

Sales rose 7 percent in the period to 565.3 million euros from a year earlier, the Novo Mesto-based company said in regulatory filing today.

Krka’s full-year profit target is 170 million euros on sales of 1.13 billion euros, the company said in the statement.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE